ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: PUB089

In Vitro Evaluation of a Continuous Potassium Monitoring System in Simulated Dialysis Conditions

Session Information

Category: Bioengineering

  • 400 Bioengineering

Authors

  • Valsamis, Jean-Baptiste, Proton Intelligence Australia, Pty Ltd., Melbourne, Victoria, Australia
  • Roshni, Rita, Proton Intelligence Australia, Pty Ltd., Melbourne, Victoria, Australia
  • Devendran, Citsabehsan, Proton Intelligence Australia, Pty Ltd., Melbourne, Victoria, Australia
  • Lin, Fenge, Proton Intelligence Australia, Pty Ltd., Melbourne, Victoria, Australia
  • Wang, Kaixuan, Proton Intelligence Australia, Pty Ltd., Melbourne, Victoria, Australia
  • Lensing, Cody J., Proton Intelligence, Inc., Vancouver, British Columbia, Canada
  • Ranamukha, Sahan, Proton Intelligence Australia, Pty Ltd., Melbourne, Victoria, Australia
  • Cadarso, Victor J, Proton Intelligence Australia, Pty Ltd., Melbourne, Victoria, Australia
Background

Potassium (K+) dysregulation is a life-threatening condition. During a dialysis session, a patient’s K+ levels often begin above the normal range and end below the normal range, before rebounding after the session. We have developed a continuous K+ monitor (CKM) capable of measuring dynamic K+ levels in real-time. In this report, we mimic dialysis conditions in vitro to characterize the sensors’ ability to measure rapidly shifting K+ levels.

Methods

The potentiometric sensor probes consist of a working electrode (WE) that measures K+ directly, selectively, and sensitively and a reference electrode (RE). Eight sensors were immersed in fluid controlled by a pump system able to control K+ levels. We simulated dialysis conditions over 5 hours by changing K+ concentration from 7 mmol/L to 4.5 mmol/L and back to 6 mmol/L. The electrical potential was recorded every 30 seconds, and analyzed by retrofitting to the K+ concentration using a 3 parameters function to account for sensitivity, offset, and drift. Parameters were estimated for each sensor individually using least square fit method.

Results

All sensors responded rapidly during K+ changes (Figure). One sensor showed a faulty RE and one showed a time lag of 15 minutes, and were excluded. With the 6 remaining sensors, the average sensitivity was 48 ± 3.5 mV/dec, the drift was 0.84 ± 0.24 mV/h, and the offset was 2.87 ± 14.2 mV. Compared to the programed K+ profile, MARD was <1% and average accuracy was <0.1 mmol/L (defined as the standard deviation of the difference between estimated K+ and reference K+).

Conclusion

The CKM sensors responded accurately to changing K+ levels across the physiological range during a simulated dialysis session. In vivo testing is needed to further support these results.

Figure: CKM sensor probes tested in a simulated in vitro dialysis session. Profile represents the programmed K+ concentrations.

Funding

  • Commercial Support – Proton Intelligence, Inc.